Login to Your Account



Amylon Spins Out to Explore Tau Third Alternative in AD

By Catherine Shaffer
Staff Writer

Wednesday, November 27, 2013
Amylon LLC, a spinout of Aphios Corp., is prepared to tilt at the windmill that is Alzheimer’s disease through a chemical pathway that has defeated numerous previous attempts, including drugs from industry giant Eli Lilly and Co.

To continue reading subscribe now to Latest News

Learn More about Latest News

Already a subscriber? Sign In or Buy now to activate your subscription